Integra Lifesciences Holdings (IART) Capital Expenditures Growth (1y) (2010 - 2026)
Integra Lifesciences Holdings (IART) Capital Expenditures Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | -1.00% |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 10.38% |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 6.32% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 24.20% |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | 35.70% |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | -9.99% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 16.28% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | -4.32% |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | -6.52% |
| 10 | Integra Lifesciences Holdings | 1.29 Bn | 1.02 Bn | 219.74 Mn | -38.91% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -38.91% |
| Mar 31, 2026 | -48.66% |
| Dec 31, 2025 | -41.84% |
| Sep 30, 2025 | -48.88% |
| Jun 30, 2025 | -32.18% |
| Mar 31, 2025 | 87.00% |
| Dec 31, 2024 | 20.64% |
| Sep 30, 2024 | 126.69% |
| Jun 30, 2024 | 91.07% |
| Mar 31, 2024 | 12.85% |
| Dec 31, 2023 | 69.72% |
| Sep 30, 2023 | 42.85% |
| Jun 30, 2023 | 65.28% |
| Mar 31, 2023 | 46.96% |
| Dec 31, 2022 | -47.29% |
| Sep 30, 2022 | 25.65% |
| Jun 30, 2022 | 41.80% |
| Mar 31, 2022 | 39.70% |
| Dec 31, 2021 | 225.47% |
| Sep 30, 2021 | 8.31% |